Nivatrotamab
Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma[1].
Product Specifications
CAS Number
2278244-14-5
Product Name Alternative
Hu3F8-BsAb
UNSPSC
12352203
Target
CD2; CD3
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nivatrotamab.html
Purity
99.40
Solubility
10 mM in DMSO
Smiles
[Nivatrotamab]
Molecular Weight
(200.87 kDa)
References & Citations
[1]Shin HG, et, al. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. Int J Mol Sci. 2022 May 19;23 (10) :5686.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FITC Anti-Rat CD161 Antibody[3.2.3]](https://cdn.genprice.uk/products/763/68dd14af061270361e7d36a1/imageurl/e-ab-f1307c.webp)